Julie O’Neill
Julie O'Neill is a prominent figure in the life sciences industry, currently serving as the chairwoman of Hookipa Pharma, a Nasdaq-listed biopharmaceutical company. She has extensive experience in leadership roles within the biotechnology sector and has played a key role in navigating the company's challenges, including significant management changes and workforce reductions. Recently, she was in the news following the collapse of merger talks between Hookipa and Poolbeg Pharma, which has raised concerns about the future direction of both companies amid a turbulent market environment.
Not in the pool (under ¢1).
Recent news mentions
Julie O’Neill is recognized as one of the giants of Irish business who worked beyond the age of 65.
We need more over-65 workers, and companies need to get better at employing them – The Irish Times
Ireland· 2025-11-06
Julie O’Neill is the chairwoman of PTSB's board, which has decided to raise the 'for sale' sign.
Paschal Donohoe must use PTSB sale to find owner with vision – not just a red pen – The Irish TimesIreland· 2025-11-02
Julie O’Neill wrote a letter of apology on behalf of the HSE for the failings in care provided to the deceased teenager.
HSE apologises for failings in care provided to teenager who died by suicide – The Irish TimesIreland· 2025-04-02
Julie O’Neill is the chairwoman of Hookipa Pharma, which faced significant share declines in 2023.
Poolbeg focuses on ‘Plan B’ after US merger talks collapse – The Irish TimesIreland· 2025-02-26